Sinopharm
1099.HK
#2268
Rank
โ‚น576.33 B
Marketcap
โ‚น184.68
Share price
0.23%
Change (1 day)
-23.40%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): โ‚น196.98 B

According to Sinopharm's latest financial reports the company's current earnings (TTM) are โ‚น268.63 B. In 2022 the company made an earning of โ‚น268.63 B a decrease over its 2021 earnings that were of โ‚น273.32 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น196.98 B-26.67%
2022 โ‚น268.63 B-1.72%
2021โ‚น273.32 B11.7%
2020โ‚น244.68 B18.44%
2019โ‚น206.58 B10.85%
2018โ‚น186.37 B3.05%
2017โ‚น180.85 B36.48%
2016โ‚น132.51 B7.11%
2015โ‚น123.72 B12.38%
2014โ‚น110.09 B25.05%
2013โ‚น88.04 B22.54%
2012โ‚น71.85 B35.43%
2011โ‚น53.05 B52.24%
2010โ‚น34.84 B30.99%
2009โ‚น26.60 B60.59%
2008โ‚น16.56 B48.29%
2007โ‚น11.17 B123.29%
2006โ‚น5.00 B